364 related articles for article (PubMed ID: 15851468)
1. Crystal structure of BMP-9 and functional interactions with pro-region and receptors.
Brown MA; Zhao Q; Baker KA; Naik C; Chen C; Pukac L; Singh M; Tsareva T; Parice Y; Mahoney A; Roschke V; Sanyal I; Choe S
J Biol Chem; 2005 Jul; 280(26):25111-8. PubMed ID: 15851468
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
3. Activin A/bone morphogenetic protein (BMP) chimeras exhibit BMP-like activity and antagonize activin and myostatin.
Korupolu RV; Muenster U; Read JD; Vale W; Fischer WH
J Biol Chem; 2008 Feb; 283(7):3782-90. PubMed ID: 18056265
[TBL] [Abstract][Full Text] [Related]
4. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
5. Transforming Growth Factor-β Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding.
Aykul S; Martinez-Hackert E
J Biol Chem; 2016 May; 291(20):10792-804. PubMed ID: 26961869
[TBL] [Abstract][Full Text] [Related]
6. Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling.
Scherner O; Meurer SK; Tihaa L; Gressner AM; Weiskirchen R
J Biol Chem; 2007 May; 282(19):13934-43. PubMed ID: 17376778
[TBL] [Abstract][Full Text] [Related]
7. A new model for growth factor activation: type II receptors compete with the prodomain for BMP-7.
Sengle G; Ono RN; Lyons KM; Bächinger HP; Sakai LY
J Mol Biol; 2008 Sep; 381(4):1025-39. PubMed ID: 18621057
[TBL] [Abstract][Full Text] [Related]
8. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
Weber D; Kotzsch A; Nickel J; Harth S; Seher A; Mueller U; Sebald W; Mueller TD
BMC Struct Biol; 2007 Feb; 7():6. PubMed ID: 17295905
[TBL] [Abstract][Full Text] [Related]
9. The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists.
Nickel J; Dreyer MK; Kirsch T; Sebald W
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S7-14. PubMed ID: 11263668
[TBL] [Abstract][Full Text] [Related]
10. The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly.
Greenwald J; Groppe J; Gray P; Wiater E; Kwiatkowski W; Vale W; Choe S
Mol Cell; 2003 Mar; 11(3):605-17. PubMed ID: 12667445
[TBL] [Abstract][Full Text] [Related]
11. Identification of the ligand-binding site of the BMP type IA receptor for BMP-4.
Hatta T; Konishi H; Katoh E; Natsume T; Ueno N; Kobayashi Y; Yamazaki T
Biopolymers; 2000; 55(5):399-406. PubMed ID: 11241215
[TBL] [Abstract][Full Text] [Related]
12. An activin-A/C chimera exhibits activin and myostatin antagonistic properties.
Muenster U; Harrison CA; Donaldson C; Vale W; Fischer WH
J Biol Chem; 2005 Nov; 280(44):36626-32. PubMed ID: 16129674
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the BMP-2-BRIA ectodomain complex.
Kirsch T; Sebald W; Dreyer MK
Nat Struct Biol; 2000 Jun; 7(6):492-6. PubMed ID: 10881198
[TBL] [Abstract][Full Text] [Related]
14. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways.
Nohe A; Hassel S; Ehrlich M; Neubauer F; Sebald W; Henis YI; Knaus P
J Biol Chem; 2002 Feb; 277(7):5330-8. PubMed ID: 11714695
[TBL] [Abstract][Full Text] [Related]
15. Mouse smad8 phosphorylation downstream of BMP receptors ALK-2, ALK-3, and ALK-6 induces its association with Smad4 and transcriptional activity.
Kawai S; Faucheu C; Gallea S; Spinella-Jaegle S; Atfi A; Baron R; Roman SR
Biochem Biophys Res Commun; 2000 May; 271(3):682-7. PubMed ID: 10814522
[TBL] [Abstract][Full Text] [Related]
16. mRNA expression of type I and type II receptors for activin, transforming growth factor-beta, and bone morphogenetic protein in the murine erythroleukemic cell line, F5-5.fl.
Machida H; Ogawa K; Funaba M; Mizutani T; Tsujimoto M
Eur J Endocrinol; 2000 Nov; 143(5):705-10. PubMed ID: 11078996
[TBL] [Abstract][Full Text] [Related]
17. Targeting of bone morphogenetic protein growth factor complexes to fibrillin.
Sengle G; Charbonneau NL; Ono RN; Sasaki T; Alvarez J; Keene DR; Bächinger HP; Sakai LY
J Biol Chem; 2008 May; 283(20):13874-88. PubMed ID: 18339631
[TBL] [Abstract][Full Text] [Related]
18. Structure of the ternary signaling complex of a TGF-beta superfamily member.
Allendorph GP; Vale WW; Choe S
Proc Natl Acad Sci U S A; 2006 May; 103(20):7643-8. PubMed ID: 16672363
[TBL] [Abstract][Full Text] [Related]
19. BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors.
Allendorph GP; Isaacs MJ; Kawakami Y; Izpisua Belmonte JC; Choe S
Biochemistry; 2007 Oct; 46(43):12238-47. PubMed ID: 17924656
[TBL] [Abstract][Full Text] [Related]
20. Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome.
Kotzsch A; Nickel J; Seher A; Heinecke K; van Geersdaele L; Herrmann T; Sebald W; Mueller TD
J Biol Chem; 2008 Feb; 283(9):5876-87. PubMed ID: 18160401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
